Berger Financial Group, Inc Regeneron Pharmaceuticals, Inc. Transaction History
Berger Financial Group, Inc
- $1.22 Billion
- Q4 2024
A detailed history of Berger Financial Group, Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Berger Financial Group, Inc holds 385 shares of REGN stock, worth $262,034. This represents 0.02% of its overall portfolio holdings.
Number of Shares
385
Previous 391
1.53%
Holding current value
$262,034
Previous $411,000
33.33%
% of portfolio
0.02%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding REGN
# of Institutions
1,493Shares Held
85.8MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.32 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.75 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.8 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.29 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.22 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $73B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...